These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11773907)

  • 1. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics.
    Hoffman TM; Wernovsky G; Atz AM; Bailey JM; Akbary A; Kocsis JF; Nelson DP; Chang AC; Kulik TJ; Spray TL; Wessel DL
    Am Heart J; 2002 Jan; 143(1):15-21. PubMed ID: 11773907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
    Hoffman TM; Wernovsky G; Atz AM; Kulik TJ; Nelson DP; Chang AC; Bailey JM; Akbary A; Kocsis JF; Kaczmarek R; Spray TL; Wessel DL
    Circulation; 2003 Feb; 107(7):996-1002. PubMed ID: 12600913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery: A Double-Blind Randomized Clinical Pilot Study Comparing Dobutamine and Milrinone.
    Cavigelli-Brunner A; Hug MI; Dave H; Baenziger O; Buerki C; Bettex D; Cannizzaro V; Balmer C
    Pediatr Crit Care Med; 2018 Jul; 19(7):619-625. PubMed ID: 29538053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
    Burkhardt BE; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009515. PubMed ID: 25806562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study.
    Lechner E; Hofer A; Leitner-Peneder G; Freynschlag R; Mair R; Weinzettel R; Rehak P; Gombotz H
    Pediatr Crit Care Med; 2012 Sep; 13(5):542-8. PubMed ID: 22622649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial.
    Wang A; Cui C; Fan Y; Zi J; Zhang J; Wang G; Wang F; Wang J; Tan Q
    Crit Care; 2019 Dec; 23(1):428. PubMed ID: 31888711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of empiric nesiritide or milrinone infusion on early postoperative recovery after Fontan surgery: a randomized, double-blind, placebo-controlled trial.
    Costello JM; Dunbar-Masterson C; Allan CK; Gauvreau K; Newburger JW; McGowan FX; Wessel DL; Mayer JE; Salvin JW; Dionne RE; Laussen PC
    Circ Heart Fail; 2014 Jul; 7(4):596-604. PubMed ID: 24906491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial.
    Thorlacius EM; Suominen PK; Wåhlander H; Keski-Nisula J; Vistnes M; Ricksten SE; Synnergren M; Romlin BS; Castellheim A
    Pediatr Crit Care Med; 2019 Oct; 20(10):947-956. PubMed ID: 31274775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparative study of intravenous infusion of three different fixed doses of milrinone in pediatric patients with pulmonary hypertension undergoing open heart surgery.
    Barnwal NK; Umbarkar SR; Sarkar MS; Dias RJ
    Ann Card Anaesth; 2017; 20(3):318-322. PubMed ID: 28701597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
    Loh E; Elkayam U; Cody R; Bristow M; Jaski B; Colucci WS
    J Card Fail; 2001 Jun; 7(2):114-21. PubMed ID: 11420762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.
    Vogt W
    Clin Pharmacokinet; 2014 Jan; 53(1):51-72. PubMed ID: 23839530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of levosimendan vs milrinone in preventing low cardiac output syndrome following pediatric cardiac surgery.
    Jothinath K; Balakrishnan S; Raju V; Menon S; Osborn J
    Ann Card Anaesth; 2021; 24(2):217-223. PubMed ID: 33884979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
    JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic effects of milrinone with and without a bolus loading infusion.
    Baruch L; Patacsil P; Hameed A; Pina I; Loh E
    Am Heart J; 2001 Feb; 141(2):266-73. PubMed ID: 11174341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive Oxylipins in Infants and Children With Congenital Heart Disease Undergoing Pediatric Cardiopulmonary Bypass.
    Kim-Campbell N; Gretchen C; Ritov VB; Kochanek PM; Balasubramani GK; Kenny E; Sharma M; Viegas M; Callaway C; Kagan VE; Bayír H
    Pediatr Crit Care Med; 2020 Jan; 21(1):33-41. PubMed ID: 31305328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock.
    Lindsay CA; Barton P; Lawless S; Kitchen L; Zorka A; Garcia J; Kouatli A; Giroir B
    J Pediatr; 1998 Feb; 132(2):329-34. PubMed ID: 9506650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC trial): a randomised controlled trial.
    Schlapbach LJ; Horton SB; Long DA; Beca J; Erickson S; Festa M; d'Udekem Y; Alphonso N; Winlaw D; Johnson K; Delzoppo C; van Loon K; Gannon B; Fooken J; Blumenthal A; Young P; Jones M; Butt W; Schibler A;
    BMJ Open; 2019 Aug; 9(8):e026664. PubMed ID: 31420383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators.
    Seino Y; Momomura S; Takano T; Hayakawa H; Katoh K
    Crit Care Med; 1996 Sep; 24(9):1490-7. PubMed ID: 8797620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of milrinone on metabolism after cardiopulmonary bypass.
    Tatlis A; Papakonstantinou C; Toumbouras M; Gerolioliou K; Spanos P
    J Cardiovasc Surg (Torino); 2008 Feb; 49(1):113-8. PubMed ID: 18212696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative Hydrocortisone Infusion Reduces the Prevalence of Low Cardiac Output Syndrome After Neonatal Cardiopulmonary Bypass.
    Robert SM; Borasino S; Dabal RJ; Cleveland DC; Hock KM; Alten JA
    Pediatr Crit Care Med; 2015 Sep; 16(7):629-36. PubMed ID: 25901540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.